Sree Rayalaseema Hi-Strength Hypo
492.20
+7.20(+1.48%)
Market Cap₹844.85 Cr
PE Ratio9.22
IndustryChemicals
Company Performance:
1D+1.48%
1M-3.67%
6M-4.91%
1Y-23.47%
5Y+49.83%
View Company Insightsright
More news about Sree Rayalaseema Hi-Strength Hypo
04Apr 26
Sree Rayalaseema Hi-Strength Hypo Limited Confirms Non-Applicability of Large Corporate Framework for FY26
Sree Rayalaseema Hi-Strength Hypo Limited has confirmed to stock exchanges that it does not qualify as a Large Corporate under SEBI's regulatory framework for FY26. The company reported zero outstanding borrowings as of March 31, 2026, and no credit rating, placing it outside the Large Corporate classification criteria established by SEBI Circular dated November 26, 2018.
 no imag found
18Mar 26
Sree Rayalaseema Hi-Strength Hypo Reports Zero Physical Share Transfer Requests in February 2026
Sree Rayalaseema Hi-Strength Hypo Limited reported zero physical share transfer requests during February 2026 under SEBI's special window provision. The company filed compliance reports with BSE and NSE showing nil activity across all parameters including requests received, processed, approved, and rejected. Aarthi Consultants Private Limited, the company's registrar and transfer agent, confirmed the status in accordance with SEBI Circular dated January 30, 2026.
 no imag found
14Feb 26
Sree Rayalaseema Hi-Strength Hypo Reports Q3FY26 Financial Results with Revenue of ₹14,117.40 Lakhs
Sree Rayalaseema Hi-Strength Hypo Limited reported Q3FY26 results with revenue from operations at ₹14,117.40 lakhs and net profit of ₹2,434.69 lakhs. For nine months ended December 31, 2025, revenue reached ₹50,381.93 lakhs with net profit of ₹7,212.37 lakhs, showing growth over previous year. The company operates primarily in chemicals segment with facilities in India.
 no imag found
30May 25
SREE RAYALASEEMA HI-STRENGTH HYPO Announces Dividend and Reports Mixed Q4 Results
SREE RAYALASEEMA HI-STRENGTH HYPO has released its Q4 financial results, showing a decrease in EBITDA to ₹179.00 million from ₹271.00 million year-over-year. The EBITDA margin contracted to 11.17% from 16.39%. Despite the decline, the company declared a dividend of 3.00 rupees per share.
 no imag found
1 Year Returns:-23.47%
Industry Peers
Tata Chemicals
693.10
(+0.63%)
TANFAC Industries
2,430.00
(-0.51%)
GHCL
430.15
(-1.41%)
Grauer & Weil
83.17
(+1.28%)
Chemplast Sanmar
207.31
(-2.53%)
Thirumalai Chemicals
184.05
(+0.12%)